sglt2 glp-1 news Renal outcomes of inhibitors and GLP1 agonists in clinical practice Illustration of potential synergistic effects

AUD stigma is often ignored, leading to patients' denial and waiting too long to ask for help

Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy

While most other semaglutide-based GLP-1 drugs like Ozempic are not explicitly FDA-cleared for weight loss, many physicians will prescribe one off-label if they believe its the best option for a patients health profile and weight loss needs

Only use state-licensed or FDA-registered pharmacies Purchase medications exclusively through state-licensed pharmacies or FDA-registered facilities

The exact combination depends on your medical profile and your providers clinical judgment, ensuring the treatment plan is tailored to your specific goals and health history

The dual GLP-1/GIP receptor agonist DA4-JC shows superior protective properties compared to the GLP-1 analogue liraglutide in the APP/PS1 mouse model of alzheimers disease